New FDA Warnings Regarding Osteoporosis Drugs

Many osteoporosis drugs will now be required to change their warning labels to reflect the risk of atypical fractures of the thigh and femur. According to a FDA alert, osteoporosis drugs, also known as bisphosphonates, have been linked to rare types of femur fractures. A “subtrochanteric” fracture is a rare fracture of the thigh that is just below the hip joint. A “diaphyseal” femur fracture is when a fracture along the long part of the thigh bone.

While it is not clear if osteoporosis drugs are a direct cause of rare femur fractures, there have been enough reports linking the drugs to these fractures to require a change on the warning labels. The drugs included in this category are Fosamax, Actonel, Boniva and Atelvia. A complete list is available on FDA’s website.

Prescription drugs are meant to improve a patient’s health and quality of life. Sadly, some drugs bring about more harm than good. In certain cases, drugs simply haven’t been tested enough for doctors to understand all of the potential side effects. Dangerous prescription drugs can cause catastrophic side effects, injuries or even death. Victims of unsafe drugs would be well-advised to contact a pharmaceutical liability attorney to examine their legal rights and options.

If you believe you have been harmed by a defective drug, please call the law offices of Anapol Schwarz at 866-735-2792 to discuss your unsafe drug case. Our Fosamax injury attorneys have decades of experience and a successful track record representing victims of dangerous and defective drugs. Call us today for a free consultation and comprehensive case evaluation.

Contact Information